Absci Corp
NASDAQ:ABSI

Watchlist Manager
Absci Corp Logo
Absci Corp
NASDAQ:ABSI
Watchlist
Price: 2.97 USD -1.98% Market Closed
Market Cap: $446.6m

Net Margin

-4 071.2%
Current
Declining
by 1 845.3%
vs 3-y average of -2 225.9%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-4 071.2%
=
Net Income
$-114.6m
/
Revenue
$2.8m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-4 071.2%
=
Net Income
$-114.6m
/
Revenue
$2.8m

Peer Comparison

Country Company Market Cap Net
Margin
US
Absci Corp
NASDAQ:ABSI
446.2m USD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.2T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
218.1B USD
Loading...
US
Danaher Corp
NYSE:DHR
154.8B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
36B CHF
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
274.1B CNY
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
39.3B USD
Loading...
US
Agilent Technologies Inc
NYSE:A
37.8B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.2B USD
Loading...
US
Illumina Inc
NASDAQ:ILMN
22.2B USD
Loading...

Market Distribution

Lower than 95% of companies in the United States of America
Percentile
5th
Based on 15 072 companies
5th percentile
-4 071.2%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Absci Corp
Glance View

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. The company is headquartered in Vancouver Washington, Washington and currently employs 216 full-time employees. The company went IPO on 2021-07-22. The firm has developed an Integrated Drug Creation platform to identify novel drug targets, discover biotherapeutic candidates, and generate the cell lines to manufacture them in a single process. The company uses synthetic biology technologies and deep learning artificial intelligence (AI) to predict, identify, design, construct, screen, select and scale production of biologic drug candidates, and learn from the data it generates. The firm has drug candidates in approximately nine active programs, eight of the active programs are focused on developing production cell lines for drug candidates that the Company's partners are developing. The company has one discovery program, focused on lead optimization with Astellas. The Company’s active programs include Bispecific monoclonal antibodies (mAb), Bispecific T-cell engager, Cytokine, Fab, Multivalent Fc-fusion, Plasma protein and mAb.

ABSI Intrinsic Value
1.2 USD
Overvaluation 60%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-4 071.2%
=
Net Income
$-114.6m
/
Revenue
$2.8m
What is Absci Corp's current Net Margin?

The current Net Margin for Absci Corp is -4 071.2%, which is below its 3-year median of -2 225.9%.

How has Net Margin changed over time?

Over the last 3 years, Absci Corp’s Net Margin has decreased from -1 961% to -4 071.2%. During this period, it reached a low of -4 071.2% on Sep 30, 2025 and a high of -1 304.1% on Jun 30, 2023.

Back to Top